Neuropsychiatric illness constitutes a major disease burden worldwide, yet its neurobiological substrates remain elusive. It is increasingly believed that early disturbances during critical and sensitive periods of brain development contribute to a delayed manifestation of psychiatric disease. This is especially evident from the age of disease onset distribution which peaks during adolescence, a transitional period that is accompanied with large-scale reorganization of neuronal function and connectivity. Advanced magnetic resonance imaging (MRI) techniques in experimental animals offer unique opportunities to address the gaps in our knowledge of neurodevelopmental processes and the disease mechanisms underlying neuropsychiatric illness. Thi...
RATIONALE: The psychomotor stimulant methylphenidate is used in the treatment of attention deficit h...
AbstractLongitudinal studies on brain pathology and assessment of therapeutic strategies rely on a f...
Prior studies suggest that methylphenidate, the primary pharmacological treatment for attention-defi...
Methylphenidate (MPH) is a widely prescribed stimulant drug for the treatment of attention deficit h...
Methylphenidate is a widely prescribed psychostimulant for treatment of attention deficit hyperactiv...
Methylphenidate is a widely prescribed psychostimulant for treatment of attention deficit hyperactiv...
Administration of methylphenidate (MPH, Ritalins) to children with attention deficit hyperactivity d...
Administration of methylphenidate (MPH, Ritalins) to children with attention deficit hyperactivity d...
Background: Early drug intervention in childhood disorders aims to maximize individual potential in...
Adolescence is a developmental period characterized by heightened vulnerability to illicit drug use ...
Adolescence is a developmental period characterized by heightened vulnerability to illicit drug use ...
Although the use, and misuse, of methylphenidate is increasing in childhood and adolescence, there i...
Adolescence is an age of transition when most brain structures undergo drastic modifications, becomi...
Methylphenidate (MPH) is a psychostimulant drug used to treat attention deficit hyperactivity disord...
Brain mechanisms underpinning attention deficit/hyperactivity disorder (ADHD) are incompletely under...
RATIONALE: The psychomotor stimulant methylphenidate is used in the treatment of attention deficit h...
AbstractLongitudinal studies on brain pathology and assessment of therapeutic strategies rely on a f...
Prior studies suggest that methylphenidate, the primary pharmacological treatment for attention-defi...
Methylphenidate (MPH) is a widely prescribed stimulant drug for the treatment of attention deficit h...
Methylphenidate is a widely prescribed psychostimulant for treatment of attention deficit hyperactiv...
Methylphenidate is a widely prescribed psychostimulant for treatment of attention deficit hyperactiv...
Administration of methylphenidate (MPH, Ritalins) to children with attention deficit hyperactivity d...
Administration of methylphenidate (MPH, Ritalins) to children with attention deficit hyperactivity d...
Background: Early drug intervention in childhood disorders aims to maximize individual potential in...
Adolescence is a developmental period characterized by heightened vulnerability to illicit drug use ...
Adolescence is a developmental period characterized by heightened vulnerability to illicit drug use ...
Although the use, and misuse, of methylphenidate is increasing in childhood and adolescence, there i...
Adolescence is an age of transition when most brain structures undergo drastic modifications, becomi...
Methylphenidate (MPH) is a psychostimulant drug used to treat attention deficit hyperactivity disord...
Brain mechanisms underpinning attention deficit/hyperactivity disorder (ADHD) are incompletely under...
RATIONALE: The psychomotor stimulant methylphenidate is used in the treatment of attention deficit h...
AbstractLongitudinal studies on brain pathology and assessment of therapeutic strategies rely on a f...
Prior studies suggest that methylphenidate, the primary pharmacological treatment for attention-defi...